Understanding COQ10: Biological roles and plant-derived sources

 Corresponding author: Swathi P Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution License 4.0. Understanding COQ10: Biological roles and plant-derived sources Abhinaya B, Thanuja B, Sai Harsha VJ and Swathi P * Raghu College of Pharmacy, Dakamarri, Visakhapatnam. GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 Publication history: Received on 27 August 2025; revised on 01 October 2025; accepted on 04 October 2025 Article DOI: https://doi.org/10.30574/gscbps.2025.33.1.0367 Abstract Coenzyme Q10 (CoQ10) is commercially available in two primary forms: ubiquinone, the oxidized version, and ubiquinol, the reduced form. Each form exhibits distinct absorption profiles and cost differences, influencing their use in dietary supplementation. Understanding these variations is crucial for optimizing their efficacy in clinical and healthrelated applications. This review highlights the physiological significance of CoQ10 in cellular respiration, cellular stability, and signaling pathways, framing its role in protecting cells from oxidative damage. The pharmacokinetics of CoQ10—encompassing its absorption, distribution, metabolism, and elimination—are also examined, providing a comprehensive understanding of how the body utilizes this compound. An important focus of the review is the endogenous synthesis of CoQ10, including the impact of various herbal drugs that may enhance its natural production within the body. By exploring both the supplemental and natural synthesis avenues, this review underscores the multifaceted role of CoQ10 in maintaining optimal health. Keywords: Coenzyme Q10; Ubiquinone; Cellular Respiration; Pharmacokinetics; Herbal Source 1. Introduction to Coenzyme Q₁₀ CoQ₁₀, also known as ubiquinone-10, is a naturally occurring, fat-soluble, vitamin-like quinone compound. Its name derives from “ubiquitous” because it is present in virtually every cell of the human body. Structurally, it consists of a benzoquinone ring and a polyisoprenoid side chain with 10 isoprene units in humans, hence the designation “Q₁₀” (Crane, 2001). Coenzyme Q, commonly referred to as CoQ or ubiquinone, was first discovered in 1957 by Frederick Crane and his team during their research on mitochondrial enzymes in beef heart mitochondria. Shortly after its discovery, in 1958, its full chemical structure was elucidated, identifying it as a benzoquinone compound with a long isoprenoid side chain. Because of its widespread presence in almost all living organisms, it was initially named “ubiquinone.” The sourcing is from endogenous biosynthesis, which are synthesized via the mevalonate pathway (the same pathway inhibited by statins), using precursors such as mevalonic acid and tyrosine (Clarke, 2001) and also from dietary sources found in both animal (organ meats, fatty fish) and plant-based (soy, nuts, vegetable oils, spinach, broccoli) foods, though at relatively low concentrations compared to endogenous production (StatPearls, 2023). However, as research progressed, scientists recognized its essential role as a cofactor in mitochondrial enzyme complexes, particularly within the electron transport chain, where it facilitates electron transfer and ATP synthesis. This functional significance led to its designation as “coenzyme Q,” highlighting both its ubiquity in nature and its critical involvement in cellular energy metabolism. The metabolic role is crucially based on the physiological role of CoQ₁₀. 1.1. Chemical Nature Chemically, Coenzyme Q₁₀ (CoQ₁₀) is composed of a benzoquinone ring, which serves as the redox-active head group, attached to a polyisoprenoid tail containing 10 isoprene units in humans. The quinone head undergoes reversible redox transitions between three forms: ubiquinone (oxidized form), semiquinone (radical intermediate), and ubiquinol GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 54 (reduced form). This redox cycling is fundamental to its dual role in bioenergetics and antioxidant defense, enabling efficient electron transfer in the mitochondrial respiratory chain while also neutralizing reactive oxygen species (ROS) (Turunen et al., 2004). The long hydrophobic isoprenoid side chain provides strong lipid solubility, allowing CoQ₁₀ to embed within the inner mitochondrial membrane as well as other lipid-rich environments such as cellular membranes and plasma lipoproteins, ensuring its accessibility where both energy production and oxidative protection are most needed. 1.2. Clinical and Pharmacological Significance Endogenous levels of Coenzyme Q₁₀ (CoQ₁₀) naturally decline with aging, chronic disease conditions, and the use of statin therapy, which makes supplementation an important clinical consideration. Pharmacological studies have explored CoQ₁₀ supplementation across a wide range of conditions, including cardiovascular disorders such as congestive heart failure, hypertension, and ischemic heart disease, as well as neurodegenerative diseases like Parkinson’s and Alzheimer’s. It has also shown therapeutic potential in mitochondrial cytopathies, infertility, migraine prophylaxis, and metabolic syndromes (LittarruandTiano, 2007; López-Lluch et al., 2010). By functioning both as a critical cofactor in mitochondrial energy metabolism and as a powerful nutraceutical with antioxidant and protective properties, CoQ₁₀ stands at the intersection of biochemistry, pharmacology, and clinical medicine, bridging fundamental cellular processes with therapeutic applications. 1.3. Physiological Role 1.3.1. Mitochondrial Energy Production Coenzyme Q₁₀ (CoQ₁₀) is an essential component of the mitochondrial electron transport chain, where it serves as a mobile electron carrier crucial for energy production. Within this system, CoQ₁₀ transfers electrons from Complex I (NADH dehydrogenase) and Complex II (succinate dehydrogenase) to Complex III (cytochrome bc₁ complex). This electron shuttling is a vital step in oxidative phosphorylation, the process by which cells generate adenosine triphosphate (ATP). As electrons move through the chain, protons are pumped across the inner mitochondrial membrane, creating a proton gradient that drives ATP synthase to produce ATP, the cell’s primary energy currency. Thus, CoQ₁₀ plays a pivotal role in maintaining efficient cellular respiration and sustaining the body’s energy demands. (LittarruandTiano, 2010) 1.3.2. Antioxidant Defense In its reduced form, known as ubiquinol, Coenzyme Q₁₀ acts as a powerful lipid-soluble antioxidant that safeguards cellular structures against oxidative stress. Positioned within cell membranes, ubiquinol effectively prevents the peroxidation of membrane lipids while also protecting proteins and DNA from damage caused by reactive oxygen species. An additional important function is its ability to regenerate other antioxidants, particularly vitamin E, thereby strengthening the overall antioxidant defense system of the cell. Through these combined actions, CoQ₁₀ not only supports cellular integrity but also contributes to the prevention of oxidative stress–related disorders and the maintenance of overall physiological health ([Bentinger et al., 2007]) 1.3.3. Cellular Stability and Signaling Coenzyme Q₁₀ (CoQ₁₀) contributes to cellular stability and regulation by helping maintain the structural integrity of cell membranes, protecting them from oxidative stress and damage. Beyond its antioxidant and bioenergetic roles, CoQ₁₀ also participates in essential signaling mechanisms within the cell. It regulates apoptosis, the process of programmed cell death, ensuring that damaged or unnecessary cells are efficiently removed without harming surrounding tissues. Moreover, CoQ₁₀ influences gene expression and cell signaling pathways, which are critical for cellular communication, growth, and adaptation to stress. Through these combined actions, CoQ₁₀ not only supports mitochondrial function and energy production but also helps preserve overall cellular health and balance. (LittarruandTiano, 2010) 1.3.4. Clinical Relevance Coenzyme Q₁₀ (CoQ₁₀) levels gradually decrease with age, leading to reduced mitochondrial efficiency and increased vulnerability to oxidative stress. This decline is more pronounced in individuals with chronic conditions such as heart failure, diabetes, and neurodegenerative diseases, where both impaired synthesis and higher oxidative demand contribute to deficiency. Furthermore, statin medications, widely prescribed to lower cholesterol, unintentionally reduce CoQ₁₀ biosynthesis since they block the mevalonate pathway, which is shared by both cholesterol and CoQ₁₀ production. As a result, lower CoQ₁₀ levels in these situations may impair energy metabolism, promote fatigue, and GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 55 worsen disease symptoms, underscoring its importance in maintaining cellular and systemic health (Littarru and Tiano, 2010). 1.4. Supplementation is widely studied for Coenzyme Q₁₀ (CoQ₁₀) has been widely studied for its therapeutic potential across several health conditions. In cardiovascular diseases such as heart failure and hypertension, CoQ₁₀ supplementation supports myocardial energy production and improves endothelial function, which may enhance cardiac performance and reduce oxidative stress. In neurodegenerative disorders like Parkinson’s and Alzheimer’s disease, CoQ₁₀ helps protect neurons from oxidative damage and mitochondrial dysfunction, slowing disease progression in some cases. It also plays a critical role in mitochondrial disorders by compensating for defective energy metabolism and improving muscle function. Additionally, CoQ₁₀ has shown benefits in migraine prophylaxis, likely by stabilizing mitochondrial activity and reducing neuronal excitability. In patients taking statins, which lower cholesterol but also decrease endogenous CoQ₁₀ synthesis, supplementation may help alleviate statin-associated muscle symptoms such as weakness and pain by restoring mitochondrial function and reducing oxidative stress (Hernández-Camacho et al., 2018) 1.5. Sources of Coenzyme Q10 (CoQ10) Coenzyme Q10 (CoQ10) is obtained from two primary sources: endogenous biosynthesis within the body and exogenous intake through diet or supplements. The majority of CoQ10 is produced internally via the mevalonate pathway, which also contributes to cholesterol synthesis, ensuring a steady supply to meet cellular energy demands. At the same time, dietary sources such as meat, fish, nuts, seeds, and certain oils, along with supplemental forms, provide additional support to maintain optimal levels. Since CoQ10 is an essential cofactor in mitochondrial energy metabolism and also functions as a potent antioxidant, both endogenous synthesis and external intake are vital for sustaining adequate cellular concentrations necessary for health and disease prevention. 1.5.1. Endogenous Biosynthesis The main source of Coenzyme Q₁₀ (CoQ₁₀) in humans is de novo biosynthesis within tissues, which occurs through the mevalonate pathway. This metabolic route is highly significant because it not only produces CoQ₁₀ but also generates other essential biomolecules such as cholesterol, heme A, dolichols, and prenylated proteins, all of which play critical roles in cellular structure and function (Hernández-Camacho et al., 2018). Since this pathway is central to multiple biochemical processes, any disruption—such as that caused by statin therapy—can directly affect endogenous CoQ₁₀ production, highlighting its dependence on proper mevalonate pathway activity for maintaining adequate cellular energy and antioxidant capacity. 1.5.2. CoQ10 synthesis requires: Coenzyme Q₁₀ (CoQ₁₀) biosynthesis involves two key structural components: the benzoquinone ring, derived from aromatic amino acids such as tyrosine or phenylalanine, and the isoprenoid side chain, produced through the mevalonate pathway. This complex biosynthetic process requires the coordinated activity of at least 13 nuclearencoded COQ genes, which regulate enzymatic steps including quinone head modification, side-chain attachment, and overall pathway control (Alcázar-Fabra et al., 2018). Because the mevalonate pathway is shared with cholesterol biosynthesis, drugs like statins (HMG-CoA reductase inhibitors) inadvertently reduce CoQ₁₀ production, a factor thought to contribute to statin-associated muscle symptoms or myopathy (Deichmann et al., 2010). Although CoQ₁₀ is synthesized in most human tissues, its highest concentrations are found in metabolically active organs such as the heart, kidneys, liver, and skeletal muscles, where energy demand and antioxidant protection are greatest (Crane, 2001; LittarruandTiano, 2007) 1.6. Dietary Sources Although the majority of Coenzyme Q₁₀ (CoQ₁₀) is produced endogenously through the mevalonate pathway, dietary intake also contributes to maintaining plasma and tissue levels. Typical Western diets provide an estimated 3–6 mg of CoQ₁₀ per day, primarily from foods such as meat, fish, nuts, and certain oils. However, this amount is significantly lower than the doses required for therapeutic purposes, as clinical supplementation often involves 100–300 mg per day to achieve meaningful physiological or therapeutic effects (Bhagavan and Chopra, 2006). This gap highlights why supplementation becomes necessary in conditions of deficiency, increased metabolic demand, or therapeutic interventions. GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 56 1.6.1. Animal-Based Sources (richest sources) Animal-based foods are the richest natural sources of Coenzyme Q₁₀ (CoQ₁₀), largely because they contain tissues with high mitochondrial density. Organ meats such as heart, liver, and kidney provide the highest concentrations, reflecting their intense energy requirements. Fatty fish, including sardines, mackerel, salmon, and tuna, also supply moderate to high levels, while poultry and beef contribute appreciable amounts. For example, beef heart has been reported to contain up to 113 μg of CoQ₁₀ per gram of fresh weight, making it one of the most concentrated dietary sources (Mattila et al., 2000). These animal-derived foods, therefore, play a key role in supporting dietary CoQ₁₀ intake, especially in diets with high metabolic or therapeutic demands. 1.6.2. Plant-Based Sources (lower but important for vegetarians/vegans) Plant-based foods also contribute to dietary Coenzyme Q₁₀ (CoQ₁₀), though typically at lower levels compared to animal sources. Nuts and seeds such as peanuts, sesame seeds, and pistachios provide modest amounts, while vegetable oils— including soybean, canola, and olive oil—are among the most significant plant-derived sources. Soy products like tofu and soybeans add further to intake, and leafy vegetables such as spinach, broccoli, and cauliflower contain measurable, though relatively lower, concentrations. Notably, soybean oil has been reported to contain between 54–160 μg of CoQ₁₀ per gram, making it one of the richest plant sources available (Weber et al., 1997). These plant foods are particularly valuable in supporting CoQ₁₀ intake for individuals following vegetarian or vegan diets. 1.6.3. Dairy and Other Foods Milk, dairy products, and whole grains contribute only small amounts of Coenzyme Q₁₀ (CoQ₁₀) to the diet compared to animal meats, fish, or certain plant oils. While these foods are not major sources, they still provide minor contributions that can help support overall intake, particularly when consumed regularly as part of a balanced diet. In populations with limited access to richer sources of CoQ₁₀, such as organ meats or fatty fish, these modest contributions from dairy and whole grains may still play a supplementary role in maintaining baseline plasma and tissue levels of CoQ₁₀. 1.6.4. Supplemental Sources Since dietary intake of Coenzyme Q₁₀ (CoQ₁₀) is relatively low, nutritional supplements represent the primary exogenous source for achieving pharmacological doses. These supplements are available in different forms, including ubiquinone (oxidized), ubiquinol (reduced), and various solubilized formulations, each differing in their absorption and bioavailability (López-Lluch et al., 2010). Because CoQ₁₀ is highly lipophilic and poorly soluble in water, its bioavailability can vary widely depending on the formulation. To overcome this challenge, novel delivery systems such as liposomes, nanoparticles, micelles, and self-emulsifying drug delivery systems (SEDDS) have been developed to enhance absorption and improve therapeutic efficacy (BhagavanandChopra, 2006). These advancements make supplementation a practical and effective strategy to maintain optimal CoQ₁₀ levels, especially in clinical settings where higher doses are required. Numerous companies are now offering CoQ₁₀ supplements, often combined with other health supplements and multivitamin tablets (Table 2). It's important to highlight the value of sourcing CoQ₁₀ from herbal origins. Natural sources of CoQ₁₀, such as spinach, broccoli, and whole grains, not only provide this essential nutrient but also come packed with additional vitamins, minerals, and antioxidants. These herbal sources can enhance absorption and efficacy, aligning with a holistic approach to health. As consumers increasingly seek natural and plantbased options, prioritizing herbal sources of CoQ₁₀ can contribute significantly to overall well-being. GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 57 Table 1 Comparison with the marketed products Brand / Product Form (active) Typical dose (common SKU) Pros Cons and cautions Reference Qunol Ubiquinol (Mega / Ultra) Ubiquinol (reduced) 100 mg softgels (60–120 ct) Easily available; marketed for higher absorption; many user reviews; good for older adults or those who struggle converting ubiquinone → ubiquinol. More expensive than standard ubiquinone; softgels may contain non-vegan ingredients. Lopez-Lluch et al. (2019) Life Extension — Super Ubiquinol CoQ10 Ubiquinol (Kaneka) 100 mg softgels Uses Kaneka ubiquinol ingredient; premium brand with clinical references; aimed at cardiovascular support. Higher price; contains oils/softgel excipients. López-Lluch et al. (2019) Kaneka Ubiquinol (ingredient) Ubiquinol (ingredient brand) N/A (sold as ingredient) Widely used industry standard; backed by safety/clinical data — many brands use it. Ingredient (not finished supplement) — check label to confirm brand use. Hosoe et al. (2007) MitoQ (Mitoquinone) Mitoquinone (mitotargeted) — not CoQ10 10 mg daily, typical Mito-targeted antioxidant with strong absorption into mitochondria; low dose due to potency. Useful when mitochondrial delivery is desired. Different molecule (not interchangeable with CoQ10); clinical effects differ; costlier. Méndez, B. R., et al. (2021) Ubiqsome / CoQ10 Phytosome (sold under many labels, e.g., Solaray ProSorb, Super Nutrition) Ubiqsome® (Indena) — Phytosome (ubiquinone in phospholipid matrix) 100–300 mg (phytosome dose; typical 100–300 mg equiv.) Improved bioavailability vs standard CoQ10 in studies/ex vivo and clinical signals for better muscle uptake and endothelial function. Good option when absorption is a concern. Proprietary ingredient — premium price; evidence promising but heterogeneous; verify the amount of actual CoQ10 (standardized %). Cicero et al. (2022) Jarrow Formulas — QAbsorb / Q-Absorb Proliposome Ubiquinone in proliposome delivery 100 mg softgels Proliposome delivery system designed to increase absorption (human data claims). Trusted brand, vegetarian options. Proprietary delivery claims — look for third-party test info if important. Lancisi Heart Institute and University of Ancona team (2006) Doctor’s Best High Absorption CoQ10 (with BioPerine) Ubiquinone + BioPerine (black pepper extract) 100 mg (120 ct) BioPerine may increase absorption of some nutrients; cost-effective; widely available. Evidence on BioPerine specifically boosting CoQ10 uptake is limited; potential GI side effects in some. Badmaev V, Majeed M, Prakash L (2000) NOW Foods CoQ10 (fermented ubiquinone) Ubiquinone (fermentationderived) 100–200 mg caps/softgels Affordable, long-standing brand; “pharmaceutical grade”; vegan options. Standard ubiquinone may require higher doses for older Navas Lloret P, López-Lluch G, et al. GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 58 adults; check the product for excipients. 2020. Nature Made CoQ10 (USP verified options) Ubiquinone (sometimes with black pepper) 100–200 mg softgels Widely available, USP-verified SKUs available (quality assurance), and budget-friendly. Some formulations contain soy; check for third-party testing if needed. Badmaev V, Majeed M, Prakash L (2000) Garden of Life — Raw CoQ10 (vegan, foodform) Raw CoQ10 in chia seed oil (food-based) 200 mg capsule Vegan, whole-food delivery system (cold-pressed oil); attractive for “food-form” enthusiasts; sustainable brand image. Larger capsule; cost higher; clinical equivalence to purified CoQ10 not fully established. Sadek et al. (2023) Nordic Naturals CoQ10 Gummies Ubiquinone (gummy) 100 mg gummy (per gummy) Tasty, vegan/gelatin-free options; easier for people who dislike pills; third-party tested options. Gummies may include sugar; dosing inflexibility; often more expensive per mg. Mantle D, Dybring A, 2020 Thorne / Q-Best (Thorne CoQ10) Ubiquinone (optimized absorption) 100 mg gelcaps Clinician-favored brand; clean labeling, high quality control; professional channel availability. Pricier; often sold via practitioners. Judy WV (2022) Puritan’s Pride — Q-Sorb / Q-SORB™ Rapid-release CoQ10 formulations 100–200 mg softgels Very budget-friendly; large pack sizes; accessible. Variable third-party testing; cheaper formulations may use lower-grade excipients. Hernandez, M. L., et al. (2007) Life-stage / fertility combos (e.g., FullWell, Needed, Garden of Life fertility formulas) CoQ10 + antioxidants / omega-3 / vitamins CoQ10 100–400 mg + other fertility ingredients Formulated for fertility (improves oocyte quality in some studies); convenient multi-nutrient approach. Harder to attribute effects to CoQ10 alone; costlier; check for clinical evidence and interactions (e.g., high vitamin A in pregnancy). Jordan, V.,andShowell, M. G. (2020) Mito-targeted alternatives summary (MitoQ repeated) Mitoquinone 10 mg daily, typical MitoQ is intended for mitochondrial delivery; lower doses needed; distinct mechanism and clinical literature. Not a direct substitute for CoQ10 in trials — consider mechanistic differences and check indications. Jenkins, T. Carrell, D. T. (2019) GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 59 2. Physiological distribution after intake Following dietary or supplemental intake, Coenzyme Q₁₀ (CoQ₁₀) is absorbed in the small intestine, a process that requires the presence of dietary fat to facilitate its uptake due to its lipophilic nature. Once absorbed, it is incorporated into chylomicrons and transported through the lymphatic system before entering the bloodstream. In circulation, CoQ₁₀ is distributed primarily via plasma lipoproteins, including LDL, HDL, and VLDL, which act as carriers (Bhagavan and Chopra, 2006). Tissue uptake is greatest in organs with high energy demands, such as the heart, skeletal muscle, kidneys, and liver, reflecting its essential role in mitochondrial energy metabolism and antioxidant defense within these metabolically active tissues. 2.1. Pharmacokinetics of Coenzyme Q10 2.1.1. Absorption Coenzyme Q₁₀ (CoQ₁₀) is a highly lipophilic and water-insoluble compound, which makes its intestinal absorption relatively slow and limited (Bhagavan and Chopra, 2006). Its absorption mechanism closely resembles that of dietary lipids and occurs mainly in the small intestine, particularly the jejunum and ileum. For efficient uptake, CoQ₁₀ requires emulsification by bile salts and the action of pancreatic enzymes, which facilitate the formation of micelles that can be absorbed by intestinal cells (Miles, 2007). Because of this dependence on lipid digestion, the absorption efficiency of CoQ₁₀ significantly improves when it is consumed along with dietary fats, highlighting the importance of formulation and dietary context for optimizing its bioavailability. 2.1.2. Formulation impact Powder formulations of Coenzyme Q₁₀ (CoQ₁₀) generally have poor bioavailability due to the compound’s lipophilic and water-insoluble nature, which limits its intestinal absorption. To overcome this limitation, oil-based capsules, emulsified preparations, and solubilized forms of ubiquinone or ubiquinol have been developed, all of which demonstrate significantly improved absorption and plasma bioavailability compared to standard powder forms (LópezLluch et al., 2010). These enhanced formulations are particularly important in clinical and therapeutic contexts, where achieving effective systemic levels of CoQ₁₀ is necessary for its bioenergetic and antioxidant benefits. 2.1.3. Bioavailability issues The oral bioavailability of Coenzyme Q₁₀ (CoQ₁₀) in standard crystalline formulations is very low, typically estimated at only 2–3%, largely due to its poor water solubility and limited intestinal absorption. To address this challenge, advanced formulations such as solubilized preparations or nanoparticle-based delivery systems have been developed, which significantly enhance absorption efficiency. These improved systems can increase bioavailability by 2–5 fold compared to conventional crystalline CoQ₁₀, making them more effective in raising plasma and tissue levels for therapeutic use (Bhagavan and Chopra, 2006). This highlights the importance of formulation choice in ensuring optimal clinical outcomes with CoQ₁₀ supplementation. 2.2. Distribution 2.2.1. Plasma transport After intestinal absorption, Coenzyme Q₁₀ (CoQ₁₀) is packaged into chylomicrons and transported through the lymphatic system before entering systemic circulation. Once in the bloodstream, it associates with circulating lipoproteins, which act as carriers for its distribution throughout the body. The majority of plasma CoQ₁₀ is bound to low-density lipoproteins (LDL), accounting for about 58–65%, while high-density lipoproteins (HDL) carry around 20– 25% of the total CoQ₁₀ (Mohr et al., 1992). This lipoprotein-bound transport not only facilitates its delivery to tissues but also links CoQ₁₀ closely with lipid metabolism and cardiovascular health. 2.2.2. Tissue distribution Coenzyme Q₁₀ (CoQ₁₀) is widely distributed throughout the body, but its highest concentrations are found in metabolically active tissues with a high density of mitochondria, such as the heart, kidneys, liver, and skeletal muscles. This distribution reflects its critical role in supporting cellular energy production in organs with high energy demands. Within cells, CoQ₁₀ is primarily localized in the inner mitochondrial membrane, where it functions as a key electron carrier in the respiratory chain, driving ATP synthesis. In addition, it is also present in other cellular membranes, including plasma membranes, where it contributes to antioxidant defense and membrane stabilization, further extending its protective and regulatory roles beyond mitochondrial energy metabolism. GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 60 2.2.3. Physiological levels Under normal physiological conditions, plasma concentrations of Coenzyme Q₁₀ (CoQ₁₀) typically range between 0.4 and 1.9 μmol/L (Littarru and Tiano, 2007). However, tissue concentrations vary depending on metabolic activity, with the highest levels found in organs that have elevated energy demands. For example, the heart muscle, which relies heavily on continuous ATP production, can contain up to 114 μg of CoQ₁₀ per gram of tissue (Crane, 2001). This distribution pattern highlights the close relationship between CoQ₁₀ levels and energy metabolism, underscoring its vital role in maintaining optimal function in highly active tissues. 2.3. Metabolism Coenzyme Q₁₀ (CoQ₁₀) exists in three distinct redox states that enable it to function both in energy production and as an antioxidant. These include ubiquinone, the fully oxidized form; semiquinone, a short-lived radical intermediate; and ubiquinol, the fully reduced form that serves as a powerful antioxidant. In human physiology, the majority of circulating CoQ₁₀, approximately 95%, is present in the reduced ubiquinol state, which reflects its critical role in protecting lipids, proteins, and membranes from oxidative damage while simultaneously participating in mitochondrial electron transport (Kagan et al., 1990). This dynamic redox flexibility is central to its dual bioenergetic and protective functions. 2.3.1. Conversion and recycling Coenzyme Q₁₀ (CoQ₁₀) continuously cycles between its oxidized form (ubiquinone) and reduced form (ubiquinol), a process essential for its dual role in cellular function. In the mitochondrial electron transport chain, this redox cycling allows CoQ₁₀ to shuttle electrons between complexes, enabling efficient ATP production. At the same time, the conversion to ubiquinol equips it with strong antioxidant properties, allowing it to neutralize reactive oxygen species and regenerate other antioxidants such as vitamin E. This constant redox interconversion ensures that CoQ₁₀ simultaneously supports cellular energy metabolism and protects against oxidative stress, highlighting its importance as both a bioenergetic cofactor and an antioxidant defense molecule. 2.3.2. Hepatic metabolism Coenzyme Q₁₀ (CoQ₁₀) is primarily metabolized in the liver, where it undergoes reduction and various modification processes. During this metabolism, it is converted into derivatives such as CoQ₁₀-acids and CoQ₁₀-alcohols, which are then conjugated to increase their solubility. These conjugated metabolites are ultimately excreted from the body, mainly through the biliary route and to a lesser extent via urine. This metabolic pathway ensures proper turnover of CoQ₁₀ while maintaining homeostasis, allowing the body to regulate its levels in tissues and circulation. 2.4. Excretion The primary route of Coenzyme Q₁₀ (CoQ₁₀) elimination is through fecal excretion, as its metabolites are secreted via the bile into the gastrointestinal tract. In contrast, urinary excretion plays only a minimal role, with only trace amounts of CoQ₁₀ detected in urine. One notable pharmacokinetic feature of CoQ₁₀ is its relatively long plasma half-life, which ranges from approximately 33 to 65 hours depending on the formulation used and the dosing regimen (Bhagavan and Chopra, 2006; Miles, 2007). This extended half-life makes it possible to administer CoQ₁₀ in a once-daily dosing schedule for most therapeutic applications, improving patient compliance and ensuring steady plasma levels for clinical effectiveness. 2.5. Factors Affecting Pharmacokinetics Several factors influence the absorption and overall bioavailability of Coenzyme Q₁₀ (CoQ₁₀). Formulation plays a major role, as solubilized forms of ubiquinone or ubiquinol show much higher bioavailability compared to standard crystalline powders. Co-administration with food, particularly fat-containing meals, further enhances absorption because CoQ₁₀ is a lipophilic compound. Physiological factors also contribute: endogenous biosynthesis naturally declines with age, leading to reduced tissue levels, while various disease states such as cardiovascular disorders, neurodegenerative conditions, and diabetes are often associated with lower CoQ₁₀ concentrations. Drug interactions are another important consideration—statins, for example, decrease endogenous CoQ₁₀ synthesis by inhibiting the mevalonate pathway, while certain β-blockers, tricyclic antidepressants, and antihypertensive medications have also been reported to interfere with CoQ₁₀ levels. These combined influences highlight the need to optimize supplementation strategies for effective therapeutic outcomes. GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 053-065 61 2.6. Herbal (Plant-Based) Sources of Coenzyme Q10 Dietary intake of Coenzyme Q₁₀ (CoQ₁₀) in a typical diet is relatively low, averaging around 3–6 mg per day, with the majority coming from animal-based foods such as meat, fish, and poultry. However, individuals following plant-based diets can still obtain about 2–5 mg per day when their diet is optimized with CoQ₁₀-rich plant sources like nuts, seeds, soy products, and certain vegetable oils (table 1). While these dietary amounts contribute to maintaining baseline plasma and tissue levels, they remain far below the higher doses required for therapeutic purposes, which are usually achieved through supplementation. 2.7. Main Herbal/Plant Sources 2.7.1. Vegetable oils Vegetable oils are among the richest plant-based sources of Coenzyme Q₁₀ (CoQ₁₀), as its fat-soluble nature allows it to accumulate in lipid-rich foods. Oils such as soybean, canola, corn, and olive oil are particularly significant contributors, with typical concentrations ranging from 0.5 to 3 mg per 100 g of oil, which translates to about 0.1–0.5 mg per tablespoon. The method of processing also influences CoQ₁₀ content, as extra-virgin and cold-pressed oils tend to retain higher levels compared to refined oils, where heat and chemical treatments may reduce their concentration. This makes minimally processed oils an important dietary source of plant-derived CoQ₁₀, especially for individuals relying on vegetarian or vegan diets.